Cargando…

Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes

Nitrite is recognized as a bioactive nitric oxide (NO) metabolite. We have shown that nitrite inhibits platelet activation and increases platelet cGMP levels in the presence of partially deoxygenated erythrocytes. In this study, we investigated the effect of nitrite on phosphorylation of vasodilator...

Descripción completa

Detalles Bibliográficos
Autores principales: Srihirun, Sirada, Piknova, Barbora, Sibmooh, Nathawut, Schechter, Alan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837118/
https://www.ncbi.nlm.nih.gov/pubmed/29505609
http://dx.doi.org/10.1371/journal.pone.0193747
_version_ 1783304059010154496
author Srihirun, Sirada
Piknova, Barbora
Sibmooh, Nathawut
Schechter, Alan N.
author_facet Srihirun, Sirada
Piknova, Barbora
Sibmooh, Nathawut
Schechter, Alan N.
author_sort Srihirun, Sirada
collection PubMed
description Nitrite is recognized as a bioactive nitric oxide (NO) metabolite. We have shown that nitrite inhibits platelet activation and increases platelet cGMP levels in the presence of partially deoxygenated erythrocytes. In this study, we investigated the effect of nitrite on phosphorylation of vasodilator-stimulated phosphoprotein on residue serine 239 (P-VASP(Ser239)), a marker of protein kinase G (PKG) activation, in human platelets. In platelet-rich plasma (PRP), nitrite itself had no effect on levels of P-VASP(Ser239) while DEANONOate increased P-VASP(Ser239). Deoxygenation of PRP + erythrocytes (20% hematocrit) raised baseline P-VASP(Ser239) in platelets. At 20% hematocrit, nitrite (10 μM) increased P-VASP(Ser239) in platelets about 31% at 10–20 minutes of incubation while the levels of P-VASP(Ser157), a marker of protein kinase A (PKA) activation, were not changed. Nitrite increased P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes at 20–40% hematocrit, but the effects were slightly greater at 20% hematocrit. In conclusion, our data confirm that nitrite increases P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes. They also further support the idea that partially deoxygenated erythrocytes may modulate platelet activity, at least in part, via the NO/sGC/PKG pathway from NO formed by reduction of circulating nitrite ions.
format Online
Article
Text
id pubmed-5837118
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58371182018-03-19 Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes Srihirun, Sirada Piknova, Barbora Sibmooh, Nathawut Schechter, Alan N. PLoS One Research Article Nitrite is recognized as a bioactive nitric oxide (NO) metabolite. We have shown that nitrite inhibits platelet activation and increases platelet cGMP levels in the presence of partially deoxygenated erythrocytes. In this study, we investigated the effect of nitrite on phosphorylation of vasodilator-stimulated phosphoprotein on residue serine 239 (P-VASP(Ser239)), a marker of protein kinase G (PKG) activation, in human platelets. In platelet-rich plasma (PRP), nitrite itself had no effect on levels of P-VASP(Ser239) while DEANONOate increased P-VASP(Ser239). Deoxygenation of PRP + erythrocytes (20% hematocrit) raised baseline P-VASP(Ser239) in platelets. At 20% hematocrit, nitrite (10 μM) increased P-VASP(Ser239) in platelets about 31% at 10–20 minutes of incubation while the levels of P-VASP(Ser157), a marker of protein kinase A (PKA) activation, were not changed. Nitrite increased P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes at 20–40% hematocrit, but the effects were slightly greater at 20% hematocrit. In conclusion, our data confirm that nitrite increases P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes. They also further support the idea that partially deoxygenated erythrocytes may modulate platelet activity, at least in part, via the NO/sGC/PKG pathway from NO formed by reduction of circulating nitrite ions. Public Library of Science 2018-03-05 /pmc/articles/PMC5837118/ /pubmed/29505609 http://dx.doi.org/10.1371/journal.pone.0193747 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Srihirun, Sirada
Piknova, Barbora
Sibmooh, Nathawut
Schechter, Alan N.
Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
title Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
title_full Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
title_fullStr Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
title_full_unstemmed Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
title_short Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
title_sort phosphorylated vasodilator-stimulated phosphoprotein (p-vasp(ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837118/
https://www.ncbi.nlm.nih.gov/pubmed/29505609
http://dx.doi.org/10.1371/journal.pone.0193747
work_keys_str_mv AT srihirunsirada phosphorylatedvasodilatorstimulatedphosphoproteinpvaspser239inplateletsisincreasedbynitriteandpartiallydeoxygenatederythrocytes
AT piknovabarbora phosphorylatedvasodilatorstimulatedphosphoproteinpvaspser239inplateletsisincreasedbynitriteandpartiallydeoxygenatederythrocytes
AT sibmoohnathawut phosphorylatedvasodilatorstimulatedphosphoproteinpvaspser239inplateletsisincreasedbynitriteandpartiallydeoxygenatederythrocytes
AT schechteralann phosphorylatedvasodilatorstimulatedphosphoproteinpvaspser239inplateletsisincreasedbynitriteandpartiallydeoxygenatederythrocytes